UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020997
Receipt number R000024227
Scientific Title Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy
Date of disclosure of the study information 2016/04/01
Last modified on 2019/08/21 18:23:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy

Acronym

Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy

Scientific Title

Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy

Scientific Title:Acronym

Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy

Region

Japan


Condition

Condition

Hematological malignancy

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Survival rate with neutrophil engraftment on day 28 after transplantation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

1. Intra-bone infusion of cord blood cells
2. Any preconditioning including both myeloablative and non-myeloablative regimens are allowed
3. Any GVHD prophylaxis except in vivo T cell depletion are allowed

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Hematological malignancy
2. Age: 16 yr or older
3. Performance status (ECOG): 0 to 2
4. Cord blood unit: HLA-A, B, DR serotypes 4/6 match, total nuclear cell count at 2.0 x 10e7/kg or higher, prioritize cord blood unit containing more CD34 positive cells, and prioritize cord blood unit without HLA corresponding to HLA antibody in patient serum
5. Neither uncontrolled heart failure nor uncontrolled ECG abnormality
6. No need for oxygen administration
7. AST: less than 5 x ULN, ALT: less than 5 x ULN, T-Bil: less than 3 x ULN
8. Cre: less than 3 x ULN
9. Patient's agreement to participate in this study

Key exclusion criteria

1. Positive for HBs-Ag, HCV-Ab, or HIV-Ab
2. In pregnancy or breast-feeding
3. Double cancer
4. Uncontrolled psychiatric disorder
5. Uncontrolled infectious disease
6. Allergy to drugs for transplant preconditioning or GVHD prophylaxis
7. Re-transplantation within 6 months from the preceding transplantation
8. Doctor's decision

Target sample size

65


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Murata

Organization

Nagoya University Graduate School of Medicine

Division name

Hematology and Oncology

Zip code


Address

65 Tsurumai, Showa, Nagoya, Aichi, Japan

TEL

052-744-2145

Email

mmurata@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsuya Nishida

Organization

Nagoya University Graduate School of Medicine

Division name

Hematology and Oncology

Zip code


Address

65 Tsurumai, Showa, Nagoya, Aichi, Japan

TEL

052-744-2145

Homepage URL


Email

tnishida@med.nagoya-u.ac.jp


Sponsor or person

Institute

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院(愛知県)
兵庫医科大学病院(兵庫県)
岡山大学病院(岡山県)
新潟大学医歯学総合病院(新潟県)
東北大学病院(宮城県)
北海道大学病院(北海道)
川崎医科大学附属病院(岡山県)
安城更生病院(愛知県)
静岡県立静岡がんセンター(静岡県)
都立駒込病院(東京都)
島根大学医学部附属病院(島根県)
成田赤十字病院(千葉県)


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 02 Month 12 Day

Date of IRB

2016 Year 04 Month 12 Day

Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date

2019 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 12 Day

Last modified on

2019 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024227


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name